|Legal Status||Not Controlled|
No legal implications
Selective serotonin re-uptake inhibitor (SSRI). Used for the treatment of major depression, bulimia nervosa and obsessive-compulsive disorder.
|Short Term Effects||
Central nervous system features include tremor, agitation, dizziness, fatigue, drowsiness, coma and convulsions. Nausea, vomiting, dilated pupils and sweating may occur. Cardiovascular features seen with SSRIs include tachycardia, hypotension, hypertension, prolongation of QT interval and QRS duration, Torsade de Pointes, and cardiac arrest.
Death has been reported after ingestion of 6-12 g (Compton et al, 2005; Kincaid et al, 1990)
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
Fentanyls Information: UK and Ireland Drugwatch have developed an information sheet relating to Fentanyls. This information can be accessed here: http://www.thedrugswheel.com/fentanyls.php